Cargando…
Midazolam Suppresses Hepatocellular Carcinoma Cell Metastasis and Enhances Apoptosis by Elevating miR-217
BACKGROUND: Hepatocellular carcinoma (HCC) is a significant cause of human death in the world. Recently, it is found that midazolam can modulate miRs to participate in HCC progression. This research project was designed to elucidate the impacts of midazolam and miR-217 on HCC cell metastasis and apo...
Autores principales: | Shen, Qian, Xia, Yanqiong, Yang, Leilei, Wang, Bo, Peng, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926537/ https://www.ncbi.nlm.nih.gov/pubmed/35309842 http://dx.doi.org/10.1155/2022/2813521 |
Ejemplares similares
-
Retracted: Midazolam Suppresses Hepatocellular Carcinoma Cell Metastasis and Enhances Apoptosis by Elevating miR-217
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
por: Li, Zewu, et al.
Publicado: (2015) -
Retraction: MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity
Publicado: (2020) -
miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer
por: Zhang, Nan, et al.
Publicado: (2016) -
LncRNA HOTAIR Contributes to Sorafenib Resistance through Suppressing miR-217 in Hepatic Carcinoma
por: Tang, Xiaofeng, et al.
Publicado: (2020)